Human Hepatocyte Growth Factor for Chronic Limb Threatening Ischaemia: Does It Deliver?
- 8 August 2024
- journal article
- editorial
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (5) , 629-630
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysisEuropean Journal of Vascular and Endovascular Surgery, 2024
- International Union of Angiology Position Statement on no-option chronic limb threatening ischemiaInternational Angiology, 2022
- Outcomes of Conservative Treatment in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-AnalysisEuropean Journal of Vascular and Endovascular Surgery, 2021
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening IschemiaEuropean Journal of Vascular and Endovascular Surgery, 2019
- One-Year Results of First-Line Treatment Strategies in Patients With Critical Limb Ischemia (CRITISCH Registry)Journal of Endovascular Therapy, 2018
- Gene therapy in the treatment of peripheral arterial diseaseBritish Journal of Surgery, 2012